Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir.

Hepatitis C, a single-stranded RNA virus officially discovered in 1989, is one of the most known viruses of the family. Direct-acting antiviral drugs helped revolutionize the management of hepatitis C infection by guaranteeing higher cure rates. The medical field has strived to optimize the management of this disease, with recent reports proposing a shorter treatment duration to achieve the sustained virologic response (SVR).

Necrotizing Pancreatitis: To Anticoagulate or Not to Anticoagulate?

Necrotizing pancreatitis is an inflammatory process that poses a strong risk of systemic venous thromboembolism. However, it is often challenging to opt for systemic anticoagulation since the disease is also associated with an increased risk of hemorrhage. Given these opposing complications, a risk versus benefit analysis has to be employed in the management of necrotizing pancreatitis on a case-by-case basis.